GSK Says Execs May Have Broken Chinese Bribery Laws

Law360, Washington (July 22, 2013, 11:55 AM ET) -- U.K. drugmaker GlaxoSmithKline PLC announced Monday that some of its senior executives in China may have violated the law in an alleged bribery scandal in which Chinese officials claim the company paid physicians and hospitals to bolster its drug sales.

GSK's emerging markets head Abbas Hussein noted Monday that the company participated in a “very constructive” meeting with China's Ministry of Public Security over the bribery allegations, and that the pharmaceutical giant plans to cooperate with government officials' ongoing investigation and root out any corruption in...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers

Required